MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Veriheal

AUGUST 31, 2021

We are honored to present the 20 winners of Veriheal’s Innovation in Cannabis Scholarship 2021. She provides clear strategies for teaching healthcare professionals how to improve their proficiency and cultural competency for caring for medical marijuana patients. Veriheal’s Innovation in Cannabis Scholarship 2021 Winners .

Research and Development 116

Research and Development Supply Chain Programs Education 116

SpeedWeed

AUGUST 16, 2021

After receiving her PhD from the University of California at Berkeley, she was named Director of Research and Patient Services at Berkeley Patients Group, one of the oldest dispensaries in the country. . Gardening, Understanding & Advocacy . Amanda Reiman has worn many hats in the cannabis space. and abroad. . she pondered.

Chronic Pain 52

Chronic Pain Dispensary Supply Chain THC 52

Cannabis Law Report

JUNE 26, 2019

First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 10, 2019

Cannabidiol, known as CBD, is a key chemical present in plants like cannabis and hemp. Instead, CBD is fast garnering a reputation in the medical world as a potentially soothing treatment for conditions like arthritis, epilepsy , mental stress, or muscle pain, even as for certain forms of cancer.). Don’t confuse CBD with THC!

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40